Scholarly Index
Gordon J. Freeman
Dana-Farber Cancer Institute; 128,478 total citations; 608 total publications; best world rank #14
Dana-Farber Cancer Institute
128,478Total citations
608Total publications
174H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Immunology | Lifetime | 86 | US 56 | 99.86 |
| Oncology | Lifetime | 281 | US 161 | 99.54 |
| Oncology | 2021-2025 | 338 | US 141 | 96.51 |
| Immunology | 2021-2025 | 295 | US 99 | 92.79 |
| Cancer Immunotherapy and Biomarkers | Lifetime | 14 | US 8 | 99.96 |
| Immune Cell Function and Interaction | Lifetime | 54 | US 36 | 99.91 |
| Immunotherapy and Immune Responses | Lifetime | 49 | US 36 | 99.90 |
| CAR-T cell therapy research | Lifetime | 84 | US 49 | 99.67 |
| T-cell and B-cell Immunology | Lifetime | 108 | US 71 | 99.77 |
| Galectins and Cancer Biology | Lifetime | 55 | US 23 | 98.96 |
| Immune cells in cancer | Lifetime | 269 | US 108 | 98.46 |
| Phagocytosis and Immune Regulation | Lifetime | 467 | US 195 | 93.51 |
| Macrophage Migration Inhibitory Factor | Lifetime | 874 | US 344 | 81.18 |
| Immune Cell Function and Interaction | 2021-2025 | 128 | US 56 | 98.12 |
| Immunotherapy and Immune Responses | 2021-2025 | 133 | US 47 | 97.83 |
| Cancer Immunotherapy and Biomarkers | 2021-2025 | 377 | US 150 | 98.55 |
| Chemokine receptors and signaling | 2021-2025 | 972 | US 220 | 45.29 |